Data and AI

The complete stack for AI-driven drug development

Tempus uniquely combines one of the world's largest multimodal patient datasets, clinical-grade foundation models, and an agentic platform built for drug developers—so your teams move from question to evidence faster, with regulators in mind from day one.

One integrated stack, three reinforcing capabilities

Real-World Data

8.5M+ de-identified longitudinal records with linked clinical, molecular, and imaging modalities.

Foundation Models

Industry-leading multimodal models—including Virchow and PRISM for computational pathology, and TFM for multimodal oncology.

Tempus Lens

The agentic platform for oncology drug development that assembles cohorts, simulates trials, and generates fit for use evidence, fast.

Built for regulated science with biological context

Examples of some of our collaborations:

Male scientist in safety glasses and lab coat works on a computer in a lab.

Building and operating AI models on top of all Tempus data

50M real-world dataset paired with our' foundation models and compute infrastructure enables biopharma teams to train new AI models, validate existing ones to generate critical insights to improve drug development decisions.

A luminous white elliptical ring is suspended in a dark space, casting a soft reflection.

Lab-in-the-loop

One of the world's largest libraries of human ex vivo tumor-derived organoids with the same multimodal de-identified data to bring necessary biological context to preclinical drug screening, biomarker validation, and combination strategies.

 

Explore Biological Modeling →

Scientist places multiple trays of small vials into an automated laboratory machine.

Increasing PTRS

The full power of the Tempus platform working together across discovery, translational, and clinical development phases to inform indication strategy, sharpen biomarker selection, design smarter trials, and lift the probability of technical and regulatory success.

Proof in outcomes

19 of 20
largest biopharma companies build with Tempus
5x ROI
Documented 5x ROI on Lens-enabled programs
Accelerate Approval
Tempus data and models have supported FDA accelerated approval workstreams in oncology

Combining Tempus' multimodal real-world data with our development expertise lets us pressure-test trial assumptions and design studies with a higher probability of technical and regulatory success.

Bryan Campbell, SVP, Drug Development Strategy & Innovation, Bristol Myers Squibb

Ways to partner

  • License off-the-shelf foundation models or curated datasets for your in-house teams

  • Collaborate on custom analyses or models with Tempus scientists based on your needs

  • Embed Tempus Lens into your teams to run analyzes, build foundation models, and generate insights in minutes instead of months

This is AI-enabled precision medicine

This is the future of healthcare.